Adenoviral vectors for gene transfer and therapy.
Due to the very efficient nuclear entry mechanism of adenovirus and its low pathogenicity for humans, adenovirus-based vectors have become gene delivery vehicles that are widely used for transduction of different cell types, especially for quiescent, differentiated cells, in basic research, in gene therapy applications, and in vaccine development. As an important basis for their use as gene medicine, adenoviral vectors can be produced in high titers, they can transduce cells in vivo with transgenes of more than 30 kb, and they do not integrate into the host cell genome. Recent advances in the development of adenoviral vectors have brought considerable progress on issues like target cell specificity and tropism modification, long-term expression of the transgene, as well as immunogenicity and toxicity in vivo, and have suggested that the different generations of non-replicative and replicative vectors available today will each suit best for certain applications.
Center for Molecular Medicine (ZMMK) and Institute for Genetics, University of Cologne, Kerpener Str. 34, 50931 Cologne, Germany.
Christoph
C
Volpers
Stefan
S
Kochanek
D000256:Adenoviridae; D000818:Animals; D005544:Forecasting; D018390:Gene Targeting; D018014:Gene Transfer Techniques / Q000639:trends; D015316:Genetic Therapy / Q000639:trends; D005822:Genetic Vectors; D006801:Humans